Latest Breaking News On - Tissue dynamics - Page 8 : comparemela.com

Early clinical data demonstrates the efficacy of existing drug in treating COVID-19 In what has the potential to significantly change how Corona patients are being treated and the severity of the disease, research spearheaded at Jerusalem s Hebrew University gathered early clinical evidence demonstrating the efficacy of an existing drug in treating COVID-19. The study was presented at the recent SPARK Conference on Generic Drug Repurposing for COVID-19 by Professor Yaakov Nahmias, Director of the Center for Bioengineering at Hebrew University. Nahmias applied a well-established existing drug to address the buildup of fats in human lung cells caused by the SARS-CoV-2 virus. Initial lab-based results and new data from 1,500 Israel-based Corona patients have been extremely promising and clinical studies are scheduled to begin this week at Barzilai Hospital in Ashkelon, Israel, joining other clinical centers across the United States, South America and Europe.

Israel generalUnited statesHebrew universityTel avivOren shibolethShlomo maayanYaakov nahmiasFenofibrate tricorEmily hendersonIchilov medical centerSigal shafram tikva at hadassah medical centerJerusalem hebrew universityDepartment of infectious diseasesGeneric drug repurposingProfessor yaakov nahmiasBarzilai hospital